Additionally, we expect
to begin a clinical trial for individuals with TSC and subependymal giant cell astrocytoma (SEGA) by winter 2009.
For more information about clinical trials from the Tuberous Sclerosis Alliance, please click here.
For additional information regarding our research programs, please contact Kira A. Dies at (617) 919-3009 or by email at kira.dies@childrens.harvard.edu.